Switching from branded to generic antiepileptic drugs as a confounding factor and unpredictable diagnostic pitfall in epilepsy management.
Di Bonaventura
Carlo
C
Fattouch
Jinane
J
Fabbrini
Giovanni
G
Manfredi
Mario
M
Prencipe
Massimiliano
M
Giallonardo
Teresa A
TA
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000493:pharmacokinetics; D001259:Ataxia / Q000139:chemically induced; D002220:Carbamazepine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D016568:Drugs, Generic / Q000009:adverse effects* / Q000493:pharmacokinetics; D004569:Electroencephalography; D004827:Epilepsy / Q000139:chemically induced / Q000150:complications*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008279:Magnetic Resonance Imaging; D010889:Piracetam / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use
D000927:Anticonvulsants; D016568:Drugs, Generic; D002220:Carbamazepine; D000077287:Levetiracetam; D010889:Piracetam